| abstract |
REFERRING TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES CALCIUM, MAGNESIUM AND IRON SALTS, WHERE THE CALCIUM AND MAGNESIUM SALTS ARE SELECTED FROM CARBONATES, HYDROGEN CARBONATES, BASIC CARBONATES, ACETATES, MIXED OXIDES, HYDROCLOSYMES SELECT FROM IRON (III) OXIDE, IRON (III) HYDROXIDE, IRON (III) OXYHYDROXIDE AND STABILIZED FORMS OF THE SAME. THE COMPOSITION ALSO INCLUDES AN ADDITIONAL PHARMACEUTICALLY ACTIVE SUBSTANCE SUCH AS VITAMIN D, ANTIOXIDANTS SUCH AS VITAMIN E, AMINO ACIDS SUCH AS CYSTEIN, PEPTIDS SUCH AS GLUTATHION, FLAVONES, AND / OR FLAVONOIDS; THE MOLAR RATIO OF CALCIUM TO MAGNESIUM IS 1: 0.02-10; THE MOLAR RATIO OF CALCIUM TO IRON IS 1: 0.02-20. SUCH COMPOSITION HAS THE ABILITY TO ADSORB PHOSPHATE SO IT IS USEFUL IN THE TREATMENT OF PATIENTS WITH HEMODIALYSIS, HYPERPHOSPHATEMIA AND CHRONIC KIDNEY DISEASE |